{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:54:46Z","timestamp":1790956486102,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00464-026-13152-2","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:57:49Z","timestamp":1785776269000},"page":"9050-9062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Derivation and internal validation of the enhanced liver fibrosis (ELF)-based prediction score for advanced liver fibrosis in obese patients undergoing bariatric surgery"],"prefix":"10.1007","volume":"40","author":[{"given":"Saksham","family":"Gagal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brahma Kumar","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Washim Firoz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Baksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna","family":"Arumugaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemanga Kumar","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"13152_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","volume":"19","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Stepanova M, Ong J, Trimble G, AlQahtani S, Younossi I, Ahmed A, Racila A, Henry L (2021) Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States. Clin Gastroenterol Hepatol 19:580-589.e5. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.064","journal-title":"Clin Gastroenterol Hepatol"},{"key":"13152_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15:11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"13152_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fendo.2014.00164","volume":"5","author":"A Sasaki","year":"2014","unstructured":"Sasaki A, Nitta H, Otsuka K, Umemura A, Baba S, Obuchi T, Wakabayashi G (2014) Bariatric surgery and non-alcoholic fatty liver disease: current and potential future treatments. Front Endocrinol (Lausanne) 5:164. https:\/\/doi.org\/10.3389\/fendo.2014.00164","journal-title":"Front Endocrinol (Lausanne)"},{"key":"13152_CR4","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, Stal P, Wong VW-S, Kechagias S, Hultcrantz R, Loomba R (2017) Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology 65:1557\u20131565. https:\/\/doi.org\/10.1002\/hep.29085","journal-title":"Hepatology"},{"key":"13152_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology 67:328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"13152_CR6","doi-asserted-by":"publisher","first-page":"9026","DOI":"10.3748\/wjg.v20.i27.9026","volume":"20","author":"ILK Nalbantoglu","year":"2014","unstructured":"Nalbantoglu ILK, Brunt EM (2014) Role of liver biopsy in nonalcoholic fatty liver disease. World J Gastroenterol 20:9026\u20139037. https:\/\/doi.org\/10.3748\/wjg.v20.i27.9026","journal-title":"World J Gastroenterol"},{"key":"13152_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3748\/wjg.v5.i4.301","volume":"5","author":"P Thampanitchawong","year":"1999","unstructured":"Thampanitchawong P, Piratvisuth T (1999) Liver biopsy:complications and risk factors. World J Gastroenterol 5:301\u2013304. https:\/\/doi.org\/10.3748\/wjg.v5.i4.301","journal-title":"World J Gastroenterol"},{"key":"13152_CR8","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1007\/s11695-020-04996-1","volume":"31","author":"SA Alqahtani","year":"2021","unstructured":"Alqahtani SA, Golabi P, Paik JM, Lam B, Moazez AH, Elariny HA, Goodman Z, Younossi ZM (2021) Performance of noninvasive liver fibrosis tests in morbidly obese patients with nonalcoholic fatty liver disease. Obes Surg 31:2002\u20132010. https:\/\/doi.org\/10.1007\/s11695-020-04996-1","journal-title":"Obes Surg"},{"key":"13152_CR9","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41366-021-00881-8","volume":"45","author":"A Drolz","year":"2021","unstructured":"Drolz A, Wolter S, Wehmeyer MH, Piecha F, Horvatits T, Schulze zur Wiesch J, Lohse AW, Mann O, Kluwe J (2021) Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity. Int J Obes 45:2197\u20132204. https:\/\/doi.org\/10.1038\/s41366-021-00881-8","journal-title":"Int J Obes"},{"key":"13152_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/flgastro-2021-102064","volume":"55","author":"RP Myers","year":"2012","unstructured":"Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Duarte-Rojo A, Wong D, Beaton M, Levstik M, Crotty P, Elkashab M (2012) Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55:199\u2013208. https:\/\/doi.org\/10.1002\/hep.24624","journal-title":"Hepatology"},{"key":"13152_CR11","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","volume":"127","author":"WMC Rosenberg","year":"2004","unstructured":"Rosenberg WMC, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJP (2004) Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127:1704\u20131713. https:\/\/doi.org\/10.1053\/j.gastro.2004.08.052","journal-title":"Gastroenterology"},{"key":"13152_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/hep.21984","volume":"47","author":"IN Guha","year":"2008","unstructured":"Guha IN, Parkes J, Roderick P, Chattopadhyay D, Cross R, Harris S, Kaye P, Burt AD, Ryder SD, Aithal GP, Day CP, Rosenberg WM (2008) Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers. Hepatology 47:455. https:\/\/doi.org\/10.1002\/hep.21984","journal-title":"Hepatology"},{"issue":"1","key":"13152_CR13","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, Vickers AJ, Ransohoff DF, Collins GS (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Annals Int Med 162(1):W1\u2013W73. https:\/\/doi.org\/10.7326\/M14-0698","journal-title":"Annals Int Med"},{"key":"13152_CR14","doi-asserted-by":"publisher","unstructured":"SV M, Nitin K, Sambit D, Nishant R, Sanjay K (2022) ESI clinical practice guidelines for the evaluation and management of obesity in India. Indian J Endocrinol Metabol 26:295. https:\/\/doi.org\/10.4103\/2230-8210.356236","DOI":"10.4103\/2230-8210.356236"},{"key":"13152_CR15","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000023","volume":"10","author":"A Berger","year":"2019","unstructured":"Berger A, Shili S, Zuberbuhler F, Hiriart J-B, Lannes A, Chermak F, Hunault G, Foucher J, Oberti F, Fouchard-Hubert I, Cales P, de Ledinghen V, Boursier J (2019) Liver stiffness measurement with FibroScan: use the right probe in the right conditions! Clin Transl Gastroenterol 10:e00023. https:\/\/doi.org\/10.14309\/ctg.0000000000000023","journal-title":"Clin Transl Gastroenterol"},{"key":"13152_CR16","unstructured":"Siemens Healthcare Diagnostics (2022) Enhanced liver fibrosis (ELF\u2122) ADVIA centaur XP and ADVIA centaur XPT systems package insert. Siemens Healthcare Diagnostics, Tarrytown. https:\/\/content.doclib.siemens-healthineers.com\/rest\/v1\/view?document-id=879118. Accessed 16 Mar 2026"},{"key":"13152_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/flgastro-2021-102064","volume":"13","author":"AJ Archer","year":"2022","unstructured":"Archer AJ, Belfield KJ, Orr JG, Gordon FH, Abeysekera KW (2022) EASL clinical practice guidelines: non-invasive liver tests for evaluation of liver disease severity and prognosis. Frontline Gastroenterol 13:436\u2013439. https:\/\/doi.org\/10.1136\/flgastro-2021-102064","journal-title":"Frontline Gastroenterol"},{"key":"13152_CR18","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1007\/s11695-025-08267-9","volume":"35","author":"JS Barajas-Gamboa","year":"2025","unstructured":"Barajas-Gamboa JS, Khoury K, Mocanu V, Wills MV, Shin TH, Romero-Velez G, Allemang M, Strong AT, Navarrete S, Corcelles R, Guerron AD, Rodriguez J, Kroh M, Dang JT (2025) Concomitant liver biopsy during bariatric surgery: no increase in major complications or readmissions but associated with higher transfusion requirements - an analysis of the MBSAQIP database. Obes Surg 35:4752\u20134765. https:\/\/doi.org\/10.1007\/s11695-025-08267-9","journal-title":"Obes Surg"},{"key":"13152_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0016-5107(96)70192-X","volume":"43","author":"J Poniachik","year":"1996","unstructured":"Poniachik J, Bernstein DE, Reddy KR, Jeffers LJ, Coelho-Little M-E, Civantos F, Schiff ER (1996) The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 43:568\u2013571. https:\/\/doi.org\/10.1016\/S0016-5107(96)70192-X","journal-title":"Gastrointest Endosc"},{"key":"13152_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11695-007-9354-1","volume":"18","author":"C-C Chiu","year":"2008","unstructured":"Chiu C-C, Lee W-J, Wang W, Lee Y-C, Huang M-T (2008) Correlations of laparoscopy with histology and laboratory studies on liver diseases in bariatric patients. Obes Surg 18:204\u2013211. https:\/\/doi.org\/10.1007\/s11695-007-9354-1","journal-title":"Obes Surg"},{"key":"13152_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/oxfordjournals.qjmed.a069101","volume":"88","author":"R Jalan","year":"1995","unstructured":"Jalan R, Harrison DJ, Dillon JF, Elton RA, Finlayson ND, Hayes PC (1995) Laparoscopy and histology in the diagnosis of chronic liver disease. QJM 88:559\u2013564","journal-title":"QJM"},{"key":"13152_CR22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47:598\u2013607. https:\/\/doi.org\/10.1016\/j.jhep.2007.07.006","journal-title":"J Hepatol"},{"key":"13152_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","volume":"368","author":"RD Riley","year":"2020","unstructured":"Riley RD, Ensor J, Snell KIE, Harrell FE, Martin GP, Reitsma JB, Moons KGM, Collins G, van Smeden M (2020) Calculating the sample size required for developing a clinical prediction model. BMJ 368:m441. https:\/\/doi.org\/10.1136\/bmj.m441","journal-title":"BMJ"},{"key":"13152_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4254\/wjh.v9.i2.91","volume":"9","author":"S Zelber-Sagi","year":"2017","unstructured":"Zelber-Sagi S, Shoham D, Zvibel I, Abu-Abeid S, Shibolet O, Fishman S (2017) Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients. World J Hepatol 9:91\u201398. https:\/\/doi.org\/10.4254\/wjh.v9.i2.91","journal-title":"World J Hepatol"},{"key":"13152_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The elements of statistical learning: data mining, inference, and prediction","author":"T Hastie","year":"2009","unstructured":"Hastie T, Tibshirani R, Friedman J (2009) The elements of statistical learning: data mining, inference, and prediction, Second Edition. Springer, NY","edition":"Second Edition"},{"key":"13152_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"JH Friedman","year":"2010","unstructured":"Friedman JH, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33:1\u201322. https:\/\/doi.org\/10.18637\/jss.v033.i01","journal-title":"J Stat Softw"},{"key":"13152_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/9781118548387","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2013","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX (2013) Applied logistic regression, 3rd ed. Wiley, Hoboken","edition":"3rd ed"},{"key":"13152_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-16399-0","volume-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"EW Steyerberg","year":"2019","unstructured":"Steyerberg EW (2019) Clinical prediction models: a practical approach to development, validation, and updating, 2nd ed. Springer International Publishing, Cham","edition":"2nd ed"},{"key":"13152_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837\u2013845. https:\/\/doi.org\/10.2307\/2531595","journal-title":"Biometrics"},{"key":"13152_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26:565\u2013574. https:\/\/doi.org\/10.1177\/0272989X06295361","journal-title":"Med Decis Making"},{"key":"13152_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6","volume":"352","author":"AJ Vickers","year":"2016","unstructured":"Vickers AJ, Calster BV, Steyerberg EW (2016) Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ 352:i6. https:\/\/doi.org\/10.1136\/bmj.i6","journal-title":"BMJ"},{"key":"13152_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/hep.30846","volume":"71","author":"A Majumdar","year":"2020","unstructured":"Majumdar A, Campos S, Gurusamy K, Pinzani M, Tsochatzis EA (2020) Defining the minimum acceptable diagnostic accuracy of noninvasive fibrosis testing in cirrhosis: a decision analytic modeling study. Hepatology 71:627. https:\/\/doi.org\/10.1002\/hep.30846","journal-title":"Hepatology"},{"key":"13152_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32\u201335","journal-title":"Cancer"},{"key":"13152_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N (2018) Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol 68:305\u2013315. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.013","journal-title":"J Hepatol"},{"key":"13152_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jceh.2023.01.016","volume":"13","author":"KW Chow","year":"2023","unstructured":"Chow KW, Futela P, Saharan A, Saab S (2023) Comparison of guidelines for the screening, diagnosis, and noninvasive assessment of nonalcoholic fatty liver disease. J Clin Exp Hepatol 13:783. https:\/\/doi.org\/10.1016\/j.jceh.2023.01.016","journal-title":"J Clin Exp Hepatol"},{"key":"13152_CR36","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","volume":"381","author":"ZJ Ward","year":"2019","unstructured":"Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, Long MW, Gortmaker SL (2019) Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med 381:2440\u20132450. https:\/\/doi.org\/10.1056\/NEJMsa1909301","journal-title":"N Engl J Med"},{"key":"13152_CR37","doi-asserted-by":"publisher","first-page":"5023157","DOI":"10.1155\/2020\/5023157","volume":"2020","author":"M Soresi","year":"2020","unstructured":"Soresi M, Cabibi D, Giglio RV, Martorana S, Guercio G, Porcasi R, Terranova A, Lazzaro LA, Emma MR, Augello G, Cervello M, Pantuso G, Montalto G, Giannitrapani L (2020) The Prevalence of NAFLD and fibrosis in bariatric surgery patients and the reliability of noninvasive diagnostic methods. Biomed Res Int 2020:5023157. https:\/\/doi.org\/10.1155\/2020\/5023157","journal-title":"Biomed Res Int"},{"key":"13152_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67268-5","volume":"17","author":"JJ Noubiap","year":"2025","unstructured":"Noubiap JJ, Nansseu JR, Nyaga UF, Ndoadoumgue AL, Ngouo AT, Tounouga DN, Tianyi F-L, Foka AJ, Lontchi-Yimagou E, Nkeck JR, Bigna JJ (2025) Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis. Nat Commun 17:573. https:\/\/doi.org\/10.1038\/s41467-025-67268-5","journal-title":"Nat Commun"},{"issue":"2","key":"13152_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11695-020-04977-4","volume":"31","author":"L Agarwal","year":"2021","unstructured":"Agarwal L, Aggarwal S, Shalimar Yadav R, Dattagupta S, Garg H, Agarwal S (2021) Bariatric surgery in nonalcoholic fatty liver disease (NAFLD): impact assessment using paired liver biopsy and fibroscan. Obes Surg 31(2):617\u2013626","journal-title":"Obes Surg"},{"key":"13152_CR40","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","volume":"71","author":"FE M\u00f3zes","year":"2022","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, Fournier C, Staufer K, Stauber RE, Bugianesi E, Younes R, Gaia S, Lup\u0219or-Platon M, Petta S, Shima T, Okanoue T, Mahadeva S, Chan W-K, Eddowes PJ, Hirschfield GM, Newsome PN, Wong VW-S, de Ledinghen V, Fan J, Shen F, Cobbold JF, Sumida Y, Okajima A, Schattenberg JM, Labenz C, Kim W, Lee MS, Wiegand J, Karlas T, Y\u0131lmaz Y, Aithal GP, Palaniyappan N, Cassinotto C, Aggarwal S, Garg H, Ooi GJ, Nakajima A, Yoneda M, Ziol M, Barget N, Geier A, Tuthill T, Brosnan MJ, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M, Investigators LITMUS (2022) Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut 71:1006\u20131019. https:\/\/doi.org\/10.1136\/gutjnl-2021-324243","journal-title":"Gut"},{"key":"13152_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11695-016-2246-5","volume":"27","author":"GJ Ooi","year":"2017","unstructured":"Ooi GJ, Burton PR, Doyle L, Wentworth JM, Bhathal PS, Sikaris K, Cowley MA, Roberts SK, Kemp W, O\u2019Brien PE, Brown WA (2017) Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese. Obes Surg 27:115\u2013125. https:\/\/doi.org\/10.1007\/s11695-016-2246-5","journal-title":"Obes Surg"},{"key":"13152_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.soard.2017.11.032","volume":"14","author":"IN Haskins","year":"2018","unstructured":"Haskins IN, Chang J, Hanipah ZN, Singh T, Mehta N, McCullough AJ, Brethauer SA, Schauer PR, Aminian A (2018) Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease? Surg Obes Relat Dis 14:342\u2013346. https:\/\/doi.org\/10.1016\/j.soard.2017.11.032","journal-title":"Surg Obes Relat Dis"},{"key":"13152_CR43","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/MCG.0000000000001937","volume":"58","author":"V Green","year":"2024","unstructured":"Green V, Lin J, McGrath M, Lloyd A, Ma P, Higa K, Roytman M (2024) FIB-4 reliability in patients with severe obesity: lower cutoffs needed? J Clin Gastroenterol 58:825. https:\/\/doi.org\/10.1097\/MCG.0000000000001937","journal-title":"J Clin Gastroenterol"},{"key":"13152_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5023157","volume":"2020","author":"M Soresi","year":"2020","unstructured":"Soresi M, Cabibi D, Giglio RV, Martorana S, Guercio G, Porcasi R, Terranova A, Lazzaro LA, Emma MR, Augello G, Cervello M, Pantuso G, Montalto G, Giannitrapani L (2020) The prevalence of NAFLD and fibrosis in bariatric surgery patients and the reliability of noninvasive diagnostic methods. BioMed Res Int 2020:5023157. https:\/\/doi.org\/10.1155\/2020\/5023157","journal-title":"BioMed Res Int"},{"key":"13152_CR45","doi-asserted-by":"publisher","first-page":"e2008","DOI":"10.1210\/clinem\/dgab933","volume":"107","author":"S Qadri","year":"2022","unstructured":"Qadri S, Ahlholm N, L\u00f8nsmann I, Pellegrini P, Poikola A, Luukkonen PK, Porthan K, Juuti A, Sammalkorpi H, Penttil\u00e4 AK, D\u2019Ambrosio R, Soardo G, Leeming DJ, Karsdal M, Arola J, Kechagias S, Pelusi S, Ekstedt M, Valenti L, Hagstr\u00f6m H, Yki-J\u00e4rvinen H (2022) Obesity modifies the performance of fibrosis biomarkers in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 107:e2008\u2013e2020. https:\/\/doi.org\/10.1210\/clinem\/dgab933","journal-title":"J Clin Endocrinol Metab"},{"key":"13152_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/nu15112521","volume":"15","author":"V Manilla","year":"2023","unstructured":"Manilla V, Santopaolo F, Gasbarrini A, Ponziani FR (2023) Type 2 diabetes mellitus and liver disease: across the gut\u2013liver axis from fibrosis to cancer. Nutrients 15:2521. https:\/\/doi.org\/10.3390\/nu15112521","journal-title":"Nutrients"},{"key":"13152_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.108726","author":"L Rong","year":"2023","unstructured":"Rong L, Zou J, Ran W, Qi X, Chen Y, Cui H, Guo J (2023) Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2022.108726","journal-title":"Front Endocrinol"},{"key":"13152_CR48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Brandman D, Doo E, Tonascia JA, Kleiner DE, Chalasani N, Sanyal AJ (2019) Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 17:156-163.e2. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.043","journal-title":"Clin Gastroenterol Hepatol"},{"key":"13152_CR49","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.23312","volume":"51","author":"VW-S Wong","year":"2010","unstructured":"Wong VW-S, Vergniol J, Wong GL-H, Foucher J, Chan HL-Y, Le Bail B, Choi PC-L, Kowo M, Chan AW-H, Merrouche W, Sung JJ-Y, de L\u00e9dinghen V (2010) Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51:454\u2013462. https:\/\/doi.org\/10.1002\/hep.23312","journal-title":"Hepatology"},{"key":"13152_CR50","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, Bedossa P, Newsome PN (2019) Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 156:1717\u20131730. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.042","journal-title":"Gastroenterology"},{"key":"13152_CR51","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/jcm11051201","volume":"11","author":"AH Ali","year":"2022","unstructured":"Ali AH, Al Juboori A, Petroski GF, Diaz-Arias AA, Syed-Abdul MM, Wheeler AA, Ganga RR, Pitt JB, Spencer NM, Hammoud GM, Rector RS, Parks EJ, Ibdah JA (2022) The utility and diagnostic accuracy of transient elastography in adults with morbid obesity: a prospective study. J Clin Med 11:1201. https:\/\/doi.org\/10.3390\/jcm11051201","journal-title":"J Clin Med"},{"key":"13152_CR52","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/j.1365-2036.2011.04668.x","volume":"33","author":"S Petta","year":"2011","unstructured":"Petta S, Di Marco V, Camm\u00e0 C, Butera G, Cabibi D, Crax\u00ec A (2011) Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 33:1350\u20131360. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04668.x","journal-title":"Aliment Pharmacol Ther"},{"key":"13152_CR53","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s11695-014-1235-9","volume":"24","author":"S Naveau","year":"2014","unstructured":"Naveau S, Lamouri K, Pourcher G, Njik\u00e9-Nakseu M, Ferretti S, Courie R, Tranchart H, Ghinoiu M, Balian A, Pr\u00e9vot S, Perlemuter G, Dagher I (2014) The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. OBES SURG 24:1693\u20131701. https:\/\/doi.org\/10.1007\/s11695-014-1235-9","journal-title":"OBES SURG"},{"key":"13152_CR54","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jhep.2011.10.017","volume":"56","author":"V de L\u00e9dinghen","year":"2012","unstructured":"de L\u00e9dinghen V, Wong VW-S, Vergniol J, Wong GL-H, Foucher J, Chu SH-T, Bail BL, Choi PC-L, Chermak F, Yiu KK-L, Merrouche W, Chan HL-Y (2012) Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan\u00ae. J Hepatol 56:833\u2013839. https:\/\/doi.org\/10.1016\/j.jhep.2011.10.017","journal-title":"J Hepatol"},{"key":"13152_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.soard.2017.09.005","volume":"14","author":"H Garg","year":"2018","unstructured":"Garg H, Aggarwal S, Shalimar YR, Gupta SD, Agarwal L, Agarwal S (2018) Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Surg Obes Related Dis 14:81\u201391. https:\/\/doi.org\/10.1016\/j.soard.2017.09.005","journal-title":"Surg Obes Related Dis"},{"key":"13152_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14222517","volume":"14","author":"Y-W Kang","year":"2024","unstructured":"Kang Y-W, Baek Y-H, Moon S-Y (2024) Sequential diagnostic approach using FIB-4 and ELF for predicting advanced fibrosis in metabolic dysfunction-associated steatotic liver disease. Diagnostics (Basel) 14:2517. https:\/\/doi.org\/10.3390\/diagnostics14222517","journal-title":"Diagnostics (Basel)"},{"key":"13152_CR57","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jhep.2020.03.036","volume":"73","author":"Y Vali","year":"2020","unstructured":"Vali Y, Lee J, Boursier J, Spijker R, L\u00f6ffler J, Verheij J, Brosnan MJ, B\u00f6cskei Z, Anstee QM, Bossuyt PM, Zafarmand MH, Pavlides M, Levick C, Duffin K, Hyde C, Bauer T, Bedossa P, Leeming D, Daly A, Hanf R, Ortiz P, Oresic M, Schuppan D, Hanauer G, Chen Y, Shumbayawonda E, Bjerring PN, Zwinderman K (2020) Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis. J Hepatol 73:252\u2013262. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.036","journal-title":"J Hepatol"},{"key":"13152_CR58","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/apt.17385","volume":"57","author":"A Hinkson","year":"2023","unstructured":"Hinkson A, Lally H, Gibson H, Jones R, Rowe IA, Shinkins B, Parker R (2023) Meta-analysis: enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases. Aliment Pharmacol Ther 57:750\u2013762. https:\/\/doi.org\/10.1111\/apt.17385","journal-title":"Aliment Pharmacol Ther"},{"key":"13152_CR59","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke F, Horn P, Wong VW-S, Ratziu V, Bugianesi E, Francque S, Zelber-Sagi S, Valenti L, Roden M, Schick F, Yki-J\u00e4rvinen H, Gastaldelli A, Vettor R, Fr\u00fchbeck G, Dicker D (2024) EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 81:492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"},{"key":"13152_CR60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cgh.2020.10.034","volume":"78","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal AJ, Foucquier J, Younossi ZM, Harrison SA, Newsome PN, Chan WK, Yilmaz Y, De Ledinghen V, Costentin C, Zheng MH, Wai-Sun Wong V, Elkhashab M, Huss RS, Myers RP, Roux M, Labourdette A, Destro M, Fournier-Poizat C, Miette V, Sandrin L, Boursier J (2023) Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores. J Hepatol 78:247\u2013259. https:\/\/doi.org\/10.1016\/j.jhep.2022.10.034","journal-title":"J Hepatol"},{"key":"13152_CR61","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.cgh.2020.10.034","volume":"19","author":"H Patton","year":"2021","unstructured":"Patton H, Heimbach J, McCullough A (2021) AGA clinical practice update on bariatric surgery in cirrhosis: expert review. Clin Gastroenterol Hepatol 19:436\u2013445. https:\/\/doi.org\/10.1016\/j.cgh.2020.10.034","journal-title":"Clin Gastroenterol Hepatol"},{"key":"13152_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122111","volume":"13","author":"M Miedziaszczyk","year":"2021","unstructured":"Miedziaszczyk M, Ciabach P, Sza\u0142ek E (2021) The effects of bariatric surgery and gastrectomy on the absorption of drugs, vitamins, and mineral elements. Pharmaceutics 13:2111. https:\/\/doi.org\/10.3390\/pharmaceutics13122111","journal-title":"Pharmaceutics"},{"key":"13152_CR63","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1007\/s11695-024-07434-8","volume":"34","author":"G Barum","year":"2024","unstructured":"Barum G, Paladini LA, de Oliveira PGS, Moreira TR, Tovo CV, Mattos \u00c2Z (2024) Assessment of metabolic and bariatric surgery safety in patients with advanced liver fibrosis. Obes Surg 34:3173\u20133180. https:\/\/doi.org\/10.1007\/s11695-024-07434-8","journal-title":"Obes Surg"},{"key":"13152_CR64","doi-asserted-by":"publisher","first-page":"e13718","DOI":"10.1111\/obr.13718","volume":"25","author":"Chalmers, K.A., Cousins, S.E., Blazeby, J.M. and By-Band-Sleeve Trial Management Group","year":"2024","unstructured":"Chalmers, K.A., Cousins, S.E., Blazeby, J.M. and By-Band-Sleeve Trial Management Group (2024) Randomized controlled trials comparing gastric bypass, gastric band, and sleeve gastrectomy: a systematic review examining validity and applicability to wider clinical practice. Obes Reviews 25:e13718. https:\/\/doi.org\/10.1111\/obr.13718","journal-title":"Obes Reviews"},{"key":"13152_CR65","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","volume":"149","author":"G Lassailly","year":"2015","unstructured":"Lassailly G, Caiazzo R, Buob D, Pigeyre M, Verkindt H, Labreuche J, Raverdy V, Leteurtre E, Dharancy S, Louvet A, Romon M, Duhamel A, Pattou F, Mathurin P (2015) Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology 149:379\u2013388. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.014","journal-title":"Gastroenterology"},{"key":"13152_CR66","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1007\/s11695-022-06011-1","volume":"32","author":"H Zhou","year":"2022","unstructured":"Zhou H, Luo P, Li P, Wang G, Yi X, Fu Z, Sun X, Cui B, Zhu L, Zhu S (2022) Bariatric surgery improves nonalcoholic fatty liver disease: systematic review and meta-analysis. Obes Surg 32:1872\u20131883. https:\/\/doi.org\/10.1007\/s11695-022-06011-1","journal-title":"Obes Surg"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13152-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-13152-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13152-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:13:20Z","timestamp":1790954000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-026-13152-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["13152"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-13152-2","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Saksham Gagal, Bramha Kumar Rath, Washim Firoz Khan, Aditya Baksi, Prasanna Ramana, Shalimar, Archna Singh, Rajni Yadav, Sandeep Aggarwal, and Hemanga Kumar Bhattacharjee declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was granted by the Institute Ethics Committee at the All India Institute of Medical Sciences (AIIMS), New Delhi before commencement of the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}